Researchers develop bioresorbable capsule for treating hemophilia

Researchers from the Cockrell School of Engineering at the University of Texas at Austin have developed a biodegradable capsule to deliver a protein therapy for hemophilia. The research, published in the International Journal of Pharmaceutics, could provide a cheaper, less painful alternative to injections or infusions.

The capsule contains micro and nanoparticles which carry a protein therapy to treat hemophilia B. The disease is caused by a missing or defective factor IX, a clotting protein, in the blood. Access to the protein therapy is limited due to its cost and the complications brought on by needle-based drug delivery.

Get the full story at our sister site, Drug Delivery Business News.

The post Researchers develop bioresorbable capsule for treating hemophilia appeared first on MassDevice.

from MassDevice http://ift.tt/2gzta9E